Literature DB >> 9083478

Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor.

K Bäckbro1, S Löwgren, K Osterlund, J Atepo, T Unge, J Hultén, N M Bonham, W Schaal, A Karlén, A Hallberg.   

Abstract

Two cyclic, C2-symmetric HIV-1 protease inhibitors, one sulfamide and one urea derivative, both comprising phenyl ether groups in the P1/P1' positions, were cocrystallized with HIV-1 protease, and the crystal structures were determined to 2.0 A resolution. The structure of the urea 2 showed a conformation similar to that reported for the related urea 3 by Lam et al., while the sulfamide 1 adopted an unanticipated conformation in which the P1' and P2' side chains were transposed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083478     DOI: 10.1021/jm960588d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

1.  A force field with discrete displaceable waters and desolvation entropy for hydrated ligand docking.

Authors:  Stefano Forli; Arthur J Olson
Journal:  J Med Chem       Date:  2012-01-13       Impact factor: 7.446

2.  Inhibition and substrate recognition--a computational approach applied to HIV protease.

Authors:  H M Vinkers; M R de Jonge; E D Daeyaert; J Heeres; L M H Koymans; J H van Lenthe; P J Lewi; H Timmerman; P A J Janssen
Journal:  J Comput Aided Mol Des       Date:  2003-09       Impact factor: 3.686

3.  Mapping protein pockets through their potential small-molecule binding volumes: QSCD applied to biological protein structures.

Authors:  Keith Mason; Nehal M Patel; Aric Ledel; Ciamac C Moallemi; Edward A Wintner
Journal:  J Comput Aided Mol Des       Date:  2004-01       Impact factor: 3.686

4.  Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets.

Authors:  Zhi Chen; Hong-lin Li; Qi-jun Zhang; Xiao-guang Bao; Kun-qian Yu; Xiao-min Luo; Wei-liang Zhu; Hua-liang Jiang
Journal:  Acta Pharmacol Sin       Date:  2009-11-23       Impact factor: 6.150

5.  Multiple receptor conformation docking and dock pose clustering as tool for CoMFA and CoMSIA analysis - a case study on HIV-1 protease inhibitors.

Authors:  Sree Kanth Sivan; Vijjulatha Manga
Journal:  J Mol Model       Date:  2011-05-06       Impact factor: 1.810

6.  MaRe: Processing Big Data with application containers on Apache Spark.

Authors:  Marco Capuccini; Martin Dahlö; Salman Toor; Ola Spjuth
Journal:  Gigascience       Date:  2020-05-01       Impact factor: 6.524

7.  Protein pharmacophore selection using hydration-site analysis.

Authors:  Bingjie Hu; Markus A Lill
Journal:  J Chem Inf Model       Date:  2012-03-26       Impact factor: 4.956

8.  Can cyclic HIV protease inhibitors bind in a non-preferred form? An ab initio, DFT and MM-PB(GB)SA study.

Authors:  Daniel P Oehme; Robert T C Brownlee; David J D Wilson
Journal:  J Mol Model       Date:  2012-11-13       Impact factor: 1.810

9.  Crystal structure of lysine sulfonamide inhibitor reveals the displacement of the conserved flap water molecule in human immunodeficiency virus type 1 protease.

Authors:  Madhavi N L Nalam; Anik Peeters; Tim H M Jonckers; Inge Dierynck; Celia A Schiffer
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

10.  Investigation on the Anticancer Activity of Symmetric and Unsymmetric Cyclic Sulfamides.

Authors:  Jaden Jungho Jun; Divya Duscharla; Ramesh Ummanni; Paul R Hanson; Sanjay V Malhotra
Journal:  ACS Med Chem Lett       Date:  2021-01-15       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.